Welcome to our dedicated page for McKesson news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson stock.
McKesson Corporation (NYSE: MCK) is a diversified healthcare services and pharmaceutical distribution company that regularly issues news and updates relevant to investors, healthcare partners, and other stakeholders. The company describes itself as dedicated to advancing health outcomes for patients everywhere, partnering with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to deliver insights, products, and services that support access to quality care.
The McKesson news feed typically features announcements about quarterly and annual financial results, earnings release dates, and related investor webcasts. These updates often include information about fiscal guidance, long-term financial targets, and commentary on strategic priorities and business outlook shared during events such as Investor Day.
In addition to earnings and guidance, McKesson’s news includes Board actions such as dividend declarations, reflecting decisions on returning capital to shareholders. The company also issues releases on organizational and segment reporting changes, including the introduction of its North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions segments, along with portfolio developments like planned separations or divestitures.
McKesson may also appear in third-party announcements highlighting distribution agreements and collaborations that illustrate its role in pharmaceutical distribution and healthcare services. Such items can show how McKesson supports access to therapies through its distribution networks and healthcare supply chain capabilities.
For readers tracking MCK news, this page provides a centralized view of financial announcements, strategic updates, capital allocation decisions, and partnership-related developments. Regularly reviewing these items can help investors and observers understand how McKesson communicates its performance, segment evolution, and strategic focus within the healthcare and wholesale trade landscape.
The Board of Directors of McKesson Corporation (NYSE: MCK) has declared a regular dividend of 42 cents per share of common stock. This dividend will be payable on July 1, 2021, to stockholders of record on June 1, 2021. McKesson is a leader in healthcare supply chain management and partners with various stakeholders in the healthcare sector to ensure safe and cost-effective distribution of medical products.
McKesson Corporation (NYSE: MCK) will release its fourth quarter fiscal 2021 financial results after market close on Thursday, May 6, 2021. The company will host a live webcast at 4:30 PM Eastern Time to discuss these results. Investors can access the webcast via McKesson's Investor Relations website, where additional financial information will also be available.
McKesson is recognized as a leader in healthcare supply chain management and has received multiple accolades, including being named a Most Admired Company in its industry.
McKesson Corporation (NYSE:MCK) reported third-quarter fiscal 2021 results, with revenues reaching $62.6 billion, a 6% increase from the previous year. Adjusted earnings per diluted share rose 21% to $4.60, driven by strong performance in U.S. Pharmaceuticals and Medical-Surgical Solutions segments. Despite an $8.1 billion pre-tax charge related to opioid litigation, the company successfully distributed COVID-19 vaccines and raised its adjusted earnings guidance for fiscal 2021 to $16.95-$17.25. The firm plans to repurchase an additional $2.0 billion in shares, reflecting confidence in its capital strategy.
The Board of Directors of McKesson Corporation (NYSE: MCK) announced a regular dividend of 42 cents per share. This dividend will be payable on April 1, 2021, to stockholders on record as of March 2, 2021. McKesson is recognized as a leader in healthcare supply chain management and has earned accolades such as being named a Most Admired Company in the healthcare sector by FORTUNE. The company is committed to providing essential healthcare solutions, ensuring timely access to medicines and medical products.
McKesson Corporation (NYSE:MCK) will announce its third quarter fiscal 2021 financial results on February 2, 2021, before market open. A live webcast of the earnings call will begin at 8:00 AM ET. The management will also participate in notable healthcare conferences, including the Goldman Sachs 13th Annual Healthcare CEOs Unscripted Conference on January 5, 2021, and the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021. Investors can access the webcast and financial materials on McKesson's Investor Relations website.
McKesson Corporation (NYSE:MCK) has appointed Dr. Kelvin A. Baggett as the new chief impact officer, effective November 30, 2020. This role aims to enhance the company's focus on diversity, equity, inclusion, sustainability, and social impact. Dr. Baggett brings extensive healthcare leadership experience, having previously served at Health Care Navigator and Tenet Healthcare. His appointment is expected to help McKesson align its strategies with societal needs, impacting both employees and communities positively.
McKesson Corporation (NYSE: MCK) has appointed Linda Mantia as an independent director, expanding its board from 11 to 12 members, effective October 19, 2020. Mantia brings over 25 years of experience in financial services and operations, having held leadership roles at Manulife Financial and Royal Bank of Canada. Her election is expected to enhance strategic guidance during critical times for healthcare. Mantia also serves on several boards and committees, positioning her to positively impact McKesson Canada's growth initiatives.
McKesson Corporation (NYSE:MCK) is set to release its second-quarter fiscal 2021 financial results on November 3, 2020, before market open. A live webcast will be conducted at 8:00 AM Eastern Time for investors to review the results. The webcast, along with the earnings press release and financial materials, will be accessible on McKesson’s Investor Relations website.
McKesson is recognized for providing healthcare supply chain management solutions and was named one of the Most Admired Companies in the healthcare wholesaler category by FORTUNE.